Stefanie Jilg

4PUBLICATIONS
4CO-AUTHORS
Regenerative medicine (incl. stem cells)Respiratory diseasesMolecular targetsGene and molecular therapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Jul 29, 2024
MoReLife - real-life data support the potential of momelotinib as a safe and effective treatment option for cytopenic myelofibrosis patients.

Stefanie Jilg, Juliana Schwaab, Katja Sockel

|Oct 16, 2021
Comprehensive characterization of central BCL-2 family members in aberrant eosinophils and their impact on therapeutic strategies.

Timo O Odinius, Lars Buschhorn, Celina Wagner

|Nov 24, 2019
Inhibition of PLK1 by capped-dose volasertib exerts substantial efficacy in MDS and sAML while sparing healthy haematopoiesis.

Veronika Dill, Johanna Kauschinger, Richard T Hauch

|Apr 25, 2019
Venetoclax with azacitidine targets refractory MDS but spares healthy hematopoiesis at tailored dose.

Stefanie Jilg, Richard T Hauch, Johanna Kauschinger

Pageof 1

Frequent Collaborators

1 joint publications

Timo O Odinius

1 joint publications

Madlen Jentzsch

1 joint publications

Florian Heidel

1 joint publications

Petro E Petrides